Why You Should Interview Your Ketamine Provider
Choosing a ketamine troche prescriber is not passive. You are entering a medical relationship for a complex, controlled substance prescription that involves meaningful risks and requires ongoing monitoring. Your provider's answers — and how they answer — reveal whether they have the depth of knowledge, clinical rigor, and patient-centered orientation to be your partner in this treatment.
These 15 questions are organized into five categories. Bring them to your initial consultation, whether in-person or telehealth. A quality provider will welcome every question. Knowing the red flags to watch for helps you interpret the answers.
Category 1: Training and Experience
Question 1: How many patients have you treated with ketamine troches?
Why it matters: Experience is one of the strongest predictors of competent clinical management. A provider who has managed 200 patients has encountered a far wider range of responses, adverse effects, and clinical challenges than one who has managed 10.
What you're looking for: A specific, confident number with some context (e.g., "I've been treating ketamine patients since 2019, with a current patient load of about 80 active troche patients").
Red flag: Vague answers ("quite a few," "many") or deflection ("the research speaks for itself"). See our guide on finding a prescriber for where to search for qualified providers.
Question 2: What training did you complete specifically in ketamine prescribing?
Why it matters: General medical training does not prepare a clinician for the specifics of ketamine therapy. Specific training — CME courses, workshops, peer consultation — indicates the provider has invested in this subspecialty.
What you're looking for: Named training programs, professional organization membership (ASKP3), CME credits, mentorship with experienced ketamine prescribers.
Question 3: Do you have a peer consultation or supervision structure for complex cases?
Why it matters: Even experienced providers encounter patients who don't fit established protocols. Access to peer consultation indicates a culture of humility and continuous learning.
Category 2: Your Initial Evaluation
Question 4: How comprehensive is your intake evaluation?
Why it matters: Adequate evaluation protects you from being prescribed a medication you shouldn't be taking and helps the provider customize your protocol.
What you're looking for: A live conversation reviewing your psychiatric history, medical history, current medications, substance use history, and cardiovascular status. Not just a questionnaire.
Red flag: A promised quick turnaround with no mention of a comprehensive clinical interview.
Question 5: What contraindications would prevent you from prescribing?
Why it matters: Knowing what conditions disqualify patients tells you whether the provider understands the clinical boundaries of appropriate prescribing.
What you're looking for: A confident list: active psychosis, uncontrolled hypertension, certain cardiovascular conditions, pregnancy, active high-risk substance use disorders.
Red flag: "Almost everyone is a good candidate" — this is clinically inaccurate.
Question 6: What is your informed consent process?
Why it matters: Informed consent should be a substantive conversation about risks, benefits, alternatives, and what "off-label" means for compounded ketamine — not just a signature on a form.
Category 3: Protocol and Monitoring
Question 7: What does your starting protocol look like, and how do you titrate?
Why it matters: Your protocol should be individualized, not a one-size-fits-all approach. The provider should be able to describe their titration philosophy — starting dose, criteria for increases, target dose range.
What you're looking for: A clear description of starting dose, monitoring schedule, and criteria for dose adjustment. Willingness to explain the rationale.
Question 8: What monitoring do you require during and between sessions?
Why it matters: At-home ketamine requires patient monitoring to catch cardiovascular and other adverse effects. The provider should specify this clearly.
What you're looking for: At minimum — blood pressure measurement before sessions, symptom tracking between sessions, reporting of adverse effects. Some providers require blood pressure measurements during sessions.
Question 9: How often will we have follow-up appointments, and what do they cover?
Why it matters: Adequate follow-up (at minimum monthly) is essential for safe ketamine prescribing. Follow-ups should include symptom review, dose assessment, adverse effect monitoring, and discussion of any concerns.
Red flag: Follow-ups offered only quarterly, or only when you initiate contact.
Question 10: What standardized outcome measures do you use?
Why it matters: Using validated scales (PHQ-9, GAD-7, PCL-5, pain scales) allows objective tracking of treatment response, rather than relying on subjective impressions.
What you're looking for: Use of standardized measures at baseline and at regular intervals.
Category 4: Pharmacy and Medication
Question 11: Which compounding pharmacy do you work with, and why?
Why it matters: Compounding pharmacy quality is not uniform. Your prescriber should have thought carefully about which pharmacy they partner with and why.
What you're looking for: A named pharmacy with PCAB accreditation. A reason for choosing it (quality standards, potency testing, customer service for patients).
Red flag: "Any compounding pharmacy you find" — this indicates no quality oversight.
Question 12: What troche formulation do you use (dose, base, flavoring), and can it be customized?
Why it matters: Understanding the formulation helps set expectations and allows you to communicate meaningfully about your experience.
What you're looking for: Clear information about typical dose range for your indication, the troche base type, available flavors, and willingness to adjust based on patient response.
Category 5: Integration and Emergencies
Question 13: Do you provide integration therapy, or do you require it from another provider?
Why it matters: Integration is a meaningful predictor of treatment durability. A provider who ignores this dimension is offering incomplete care.
What you're looking for: Either in-house integration support, a required referral, or at minimum a strong recommendation with specific resources.
Question 14: What is your protocol if I experience significant adverse effects during or after a session?
Why it matters: Adverse events happen even in well-managed programs. The provider should have a clear response protocol.
What you're looking for: A clear description: contact information, after-hours access, specific criteria for going to an emergency room, and a defined process for medication adjustment or pause.
Question 15: What is your policy if I develop dependence concerns or the medication doesn't help?
Why it matters: Not all patients respond to ketamine, and a small subset develop problematic use patterns. A quality provider should have a plan for both scenarios.
What you're looking for: Criteria for determining non-response, alternative treatment referrals for non-responders, and honest discussion of how dependency concerns would be addressed (not dismissed).
Interpreting the Answers
A quality provider will:
- Answer every question directly and thoughtfully
- Not become defensive or dismissive
- Acknowledge uncertainty where it genuinely exists
- Provide examples from clinical experience where relevant
- Welcome your engagement as a patient advocate for your own care
A provider who becomes impatient, deflects repeatedly, makes promises that seem too good to be true, or cannot articulate the clinical rationale for their protocols deserves careful scrutiny.
The Right to Leave
After this conversation, if you do not feel confident in the provider's knowledge, clinical rigor, or patient-centeredness — you have every right to seek another evaluation. Changing providers early is far easier than managing a poorly structured ketamine program after it's underway.
Key Takeaways
- Ask all 15 questions in your initial consultation — a quality provider welcomes informed patients.
- Focus particularly on intake thoroughness, monitoring requirements, pharmacy quality, and adverse event protocols.
- Vague or defensive answers are red flags; specific, confident clinical answers are reassuring.
- You have the right to seek a second opinion or change providers if you are not satisfied.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- HHS: Telehealth — U.S. Department of Health and Human Services guide to telehealth services, regulations, and patient resources
- SAMHSA: National Helpline — Substance Abuse and Mental Health Services Administration free treatment referral and information service
Share